(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are Xenetic Biosciences, ING Group, and Niu Technologies.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Xenetic Biosciences (XBIO) | 0.67 | 5% | 2023-02-09 07:33:38 |
| 2 | ING Group (ING) | 14.16 | 3.66% | 2023-02-09 07:30:05 |
| 3 | Niu Technologies (NIU) | 4.85 | 3.41% | 2023-02-09 07:33:51 |
| 4 | Momo (MOMO) | 10.70 | 2.59% | 2023-02-09 07:13:56 |
| 5 | Gevo (GEVO) | 2.10 | 2.44% | 2023-02-09 07:12:17 |
| 6 | FuelCell Energy (FCEL) | 3.80 | 2.43% | 2023-02-09 07:11:38 |
| 7 | Arcturus Therapeutics (ARCT) | 19.98 | 1.99% | 2023-02-09 04:17:00 |
| 8 | Marvell Technology Group (MRVL) | 45.99 | 1.97% | 2023-02-09 07:13:59 |
| 9 | SNDL Inc. (SNDL) | 2.24 | 1.82% | 2023-02-09 07:32:55 |
| 10 | GlaxoSmithKline (GSK) | 36.91 | 1.62% | 2023-02-09 07:14:19 |
The three biggest losers today are Pembina Pipeline, Boston Properties, and Genworth Financial.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Pembina Pipeline (PBA) | 34.23 | -0.75% | 2023-02-09 05:18:26 |
| 2 | Boston Properties (BXP) | 72.58 | -0.66% | 2023-02-09 04:11:12 |
| 3 | Genworth Financial (GNW) | 5.61 | -0.53% | 2023-02-09 07:29:07 |
| 4 | Sun Communities (SUI) | 159.81 | -0.12% | 2023-02-09 04:42:33 |
| 5 | Koninklijke Philips (PHG) | 17.37 | -0.06% | 2023-02-09 07:33:16 |
| 6 | Vanguard Short-Term (VTIP) | 47.08 | 0% | 2023-02-09 07:23:07 |
| 7 | Paychex (PAYX) | 114.94 | 0.01% | 2023-02-09 04:07:17 |
| 8 | Garmin (GRMN) | 97.01 | 0.02% | 2023-02-09 04:12:25 |
| 9 | Cenovus Energy (CVE) | 19.51 | 0.05% | 2023-02-09 06:28:55 |
| 10 | Altria Group (MO) | 46.59 | 0.19% | 2023-02-09 07:16:32 |
Premarket Winners today
1. Xenetic Biosciences (XBIO) – Premarket: 5%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences rising 3.92% to $0.63 on Thursday while NASDAQ fell 1.68% to $11,910.52.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.34%.
Sales Growth
Xenetic Biosciences’s sales growth for the next quarter is negative 27.9%.
Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.63 at 07:34 EST, way under its 52-week high of $1.25 and way higher than its 52-week low of $0.24.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Xenetic Biosciences’s stock is considered to be overbought (>=80).
More news about Xenetic Biosciences.
2. ING Group (ING) – Premarket: 3.66%
ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Germany, Poland, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts; and offers business lending products, as well as consumer lending products, such as residential mortgage loans, term loans, and revolver and personal loans. It also provides debt capital market, working capital, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, equity market, finance, payments and cash management, and trade services and solutions, as well as savings, investment, insurance, mortgage, and digital banking services. The company serves customers, corporate clients, and financial institutions, including small and medium-sized, and mid-corporates. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
NYSE ended the session with ING Group rising 2.05% to $13.66 on Thursday, after two consecutive sessions in a row of gains. NYSE fell 0.54% to $15,934.72, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, ING Group has a trailing twelve months EPS of $0.77.
PE Ratio
ING Group has a trailing twelve months price to earnings ratio of 17.79. Meaning, the purchaser of the share is investing $17.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.45%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.3%, now sitting on 16.98B for the twelve trailing months.
More news about ING Group.
3. Niu Technologies (NIU) – Premarket: 3.41%
Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers NQi, MQi, UQi, and Gova series electric scooters and motorcycles; KQi series electric kick-scooters; NIU Aero and BQi series e-bikes; RQi and TQi series high-performance motorcycles; and YQi series hybrid motorcycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, and smart services, as well as NIU cover, which provides insurance services; NIU Care that offers maintenance and reserve services in offline service stations; and NIU Wash, which provides free wash coupon on a monthly basis. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. As of December 31, 2021, it operated through 338 city partners and 3,108 franchised stores in approximately 239 cities in the People's Republic of China; and 42 distributors in 50 countries internationally. Niu Technologies was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with Niu Technologies jumping 0.11% to $4.69 on Thursday, following the last session’s upward trend. NASDAQ fell 1.68% to $11,910.52, following the last session’s downward trend on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, Niu Technologies has a trailing twelve months EPS of $0.331.
PE Ratio
Niu Technologies has a trailing twelve months price to earnings ratio of 14.15. Meaning, the purchaser of the share is investing $14.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.34%.
Sales Growth
Niu Technologies’s sales growth for the next quarter is negative 22.5%.
Volatility
Niu Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.00%, a negative 0.31%, and a positive 5.41%.
Niu Technologies’s highest amplitude of average volatility was 4.00% (last week), 4.21% (last month), and 5.41% (last quarter).
Yearly Top and Bottom Value
Niu Technologies’s stock is valued at $4.69 at 07:34 EST, way under its 52-week high of $14.34 and way higher than its 52-week low of $2.57.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Niu Technologies’s stock is considered to be overbought (>=80).
More news about Niu Technologies.
4. Momo (MOMO) – Premarket: 2.59%
Hello Group Inc. provides mobile-based social and entertainment services in the People's Republic of China. It operates Momo platform that includes its Momo mobile application, as well as various related properties, features, functionalities, tools, and services. The company's Momo mobile application connects people and facilitates interactions based on location and interests; and various recreational activities, including live talent shows, short videos, and social games, as well as other video- and audio-based interactive experiences, such as online parties, mobile karaoke, and user participated reality shows. It also operates Tantan, a social and dating application, which enables users to find and establish romantic connections, and meet interesting people; and provides live video, quick chat, value-added, mobile marketing, and other services, as well as mobile games and audio chatrooms. In addition, it allows its platform's users to livestream a variety of content and activities that comprise talent shows, such as singing, dancing, and talk shows, as well as casual chatting, and other forms of interactions between broadcasters and viewers. The company was formerly known as Momo Inc. and changed its name to Hello Group Inc. in August 2021. Hello Group Inc. was incorporated in 2011 and is headquartered in Beijing, the People's Republic of China.
NASDAQ ended the session with Momo dropping 3.25% to $10.43 on Thursday while NASDAQ dropped 1.68% to $11,910.52.
Earnings Per Share
As for profitability, Momo has a trailing twelve months EPS of $1.49.
PE Ratio
Momo has a trailing twelve months price to earnings ratio of 6.99. Meaning, the purchaser of the share is investing $6.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.23%.
Yearly Top and Bottom Value
Momo’s stock is valued at $10.43 at 07:34 EST, below its 52-week high of $11.54 and way higher than its 52-week low of $4.09.
More news about Momo.
5. Gevo (GEVO) – Premarket: 2.44%
Gevo, Inc. operates as a renewable fuels company. It operates through four segments: Gevo, Agri-Energy, Renewable Natural Gas, and Net-Zero. The company commercializes gasoline, jet fuel, and diesel fuel to achieve zero carbon emissions, and reduce greenhouse gas emissions with sustainable alternatives. Its products also include renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. Gevo, Inc. has a strategic alliance with Axens North America, Inc. for ethanol-to-jet technology and sustainable aviation fuel commercial project development. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with Gevo sliding 4.44% to $2.05 on Thursday while NASDAQ fell 1.68% to $11,910.52.
Earnings Per Share
As for profitability, Gevo has a trailing twelve months EPS of $-0.706.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.63%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 74.3%, now sitting on 673k for the twelve trailing months.
Yearly Top and Bottom Value
Gevo’s stock is valued at $2.05 at 07:34 EST, way under its 52-week high of $5.49 and way higher than its 52-week low of $1.65.
Sales Growth
Gevo’s sales growth is 351.9% for the current quarter and 6585.2% for the next.
More news about Gevo.
6. FuelCell Energy (FCEL) – Premarket: 2.43%
FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed baseload power generation. It offers SureSource1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. It also provides SureSource Capture system that separates and concentrates carbon dioxide from the flue gases of natural gas, biomass, or coal-fired power plants, as well as industrial facilities; solid oxide fuel cell/solid oxide electrolysis cell stack technology. The company's SureSource power plants generate clean electricity, usable heat, water, and hydrogen. In addition, it provides engineering, procurement, and construction services; project financing services; and real-time monitoring and remote operation, online support system, preventative maintenance, parts and supplies, on-site and classroom training, and power plant refurbishment/recycling services, as well as technical services in the areas of plant operation and performance, and fuel processing. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.
NASDAQ ended the session with FuelCell Energy falling 3.64% to $3.71 on Thursday, after four successive sessions in a row of losses. NASDAQ slid 1.68% to $11,910.52, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.399.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.42%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FuelCell Energy’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for FuelCell Energy is 6733640 which is 40.05% below its average volume of 11233400.
Sales Growth
FuelCell Energy’s sales growth for the current quarter is 223.1%.
Moving Average
FuelCell Energy’s worth is way above its 50-day moving average of $3.22 and below its 200-day moving average of $3.73.
More news about FuelCell Energy.
7. Arcturus Therapeutics (ARCT) – Premarket: 1.99%
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus; Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for rare disease targets; CureVac AG to develop mRNA therapeutic and vaccine candidates for various indications; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc. to discover siRNA medicines for the treatment of non-alcoholic steatohepatitis. The company was founded in 2013 and is headquartered in San Diego, California.
NASDAQ ended the session with Arcturus Therapeutics falling 6.91% to $19.59 on Thursday, after four sequential sessions in a row of losses. NASDAQ dropped 1.68% to $11,910.52, following the last session’s downward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Arcturus Therapeutics has a trailing twelve months EPS of $-3.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -69.48%.
Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $19.59 at 07:34 EST, way under its 52-week high of $31.41 and way higher than its 52-week low of $11.70.
More news about Arcturus Therapeutics.
8. Marvell Technology Group (MRVL) – Premarket: 1.97%
Marvell Technology, Inc., together with its subsidiaries, designs, develops, and sells analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. It offers a portfolio of Ethernet solutions, including controllers, network adapters, physical transceivers, and switches; single or multiple core processors; ASIC; and printer System-on-a-Chip products and application processors. The company also provides a range of storage products comprising storage controllers for hard disk drives (HDD) and solid-state drives that support various host system interfaces consisting of serial attached SCSI (SAS), serial advanced technology attachment (SATA), peripheral component interconnect express, non-volatile memory express (NVMe), and NVMe over fabrics; and fiber channel products, including host bus adapters, and controllers for server and storage system connectivity. It has operations in the United States, China, Malaysia, the Philippines, Thailand, Singapore, India, Israel, Japan, South Korea, Taiwan, and Vietnam. Marvell Technology, Inc. was incorporated in 1995 and is headquartered in Wilmington, Delaware.
NASDAQ ended the session with Marvell Technology Group dropping 3.58% to $45.10 on Thursday, following the last session’s downward trend. NASDAQ dropped 1.68% to $11,910.52, following the last session’s downward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Marvell Technology Group has a trailing twelve months EPS of $-0.41.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.44%.
Volatility
Marvell Technology Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.41%, a positive 1.22%, and a positive 3.19%.
Marvell Technology Group’s highest amplitude of average volatility was 4.00% (last week), 3.29% (last month), and 3.19% (last quarter).
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Oct 5, 2022, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 0.59%.
More news about Marvell Technology Group.
9. SNDL Inc. (SNDL) – Premarket: 1.82%
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
NASDAQ ended the session with SNDL Inc. dropping 2.65% to $2.20 on Thursday while NASDAQ slid 1.68% to $11,910.52.
Earnings Per Share
As for profitability, SNDL Inc. has a trailing twelve months EPS of $-0.129.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.71%.
Volatility
SNDL Inc.’s last week, last month’s, and last quarter’s current intraday variation average was 1.31%, 0.62%, and 3.52%.
SNDL Inc.’s highest amplitude of average volatility was 3.38% (last week), 2.76% (last month), and 3.52% (last quarter).
Moving Average
SNDL Inc.’s worth is under its 50-day moving average of $2.35 and way below its 200-day moving average of $2.91.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 175% and positive 80% for the next.
More news about SNDL Inc..
10. GlaxoSmithKline (GSK) – Premarket: 1.62%
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
NYSE ended the session with GlaxoSmithKline rising 0.41% to $36.32 on Thursday while NYSE dropped 0.54% to $15,934.72.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $2.88.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 12.61. Meaning, the purchaser of the share is investing $12.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.71%.
Yearly Top and Bottom Value
GlaxoSmithKline’s stock is valued at $36.32 at 07:34 EST, way below its 52-week high of $46.97 and way above its 52-week low of $28.47.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GlaxoSmithKline’s stock is considered to be oversold (<=20).
Volatility
GlaxoSmithKline’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.12%, a negative 0.02%, and a positive 1.22%.
GlaxoSmithKline’s highest amplitude of average volatility was 0.65% (last week), 0.83% (last month), and 1.22% (last quarter).
Sales Growth
GlaxoSmithKline’s sales growth for the next quarter is negative 37.9%.
More news about GlaxoSmithKline.
Premarket Losers Today
1. Pembina Pipeline (PBA) – Premarket: -0.75%
Pembina Pipeline Corporation provides transportation and midstream services for the energy industry. It operates through three segments: Pipelines, Facilities, and Marketing & New Ventures. The Pipelines segment operates conventional, oil sands and heavy oil, and transmission assets with a transportation capacity of 3.1 millions of barrels of oil equivalent per day, ground storage of 11 millions of barrels, and rail terminalling capacity of approximately 105 thousands of barrels of oil equivalent per day serving markets and basins across North America. The Facilities segment offers infrastructure that provides customers with natural gas, condensate, and natural gas liquids (NGLs), including ethane, propane, butane, and condensate; and includes 354 thousands of barrels per day of NGL fractionation capacity, 21 millions of barrels of cavern storage capacity, and associated pipeline and rail terminalling facilities. The Marketing & New Ventures segment buys and sells hydrocarbon liquids and natural gas originating in the Western Canadian sedimentary basin and other basins. Pembina Pipeline Corporation was incorporated in 1954 and is headquartered in Calgary, Canada.
NYSE ended the session with Pembina Pipeline falling 1.39% to $34.49 on Thursday while NYSE dropped 0.54% to $15,934.72.
Earnings Per Share
As for profitability, Pembina Pipeline has a trailing twelve months EPS of $-0.7.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.77%.
More news about Pembina Pipeline.
2. Boston Properties (BXP) – Premarket: -0.66%
Boston Properties (NYSE:BXP) is the largest publicly-held developer and owner of Class A office properties in the United States, concentrated in five markets – Boston, Los Angeles, New York, San Francisco and Washington, DC. The Company is a fully integrated real estate company, organized as a real estate investment trust (REIT), that develops, manages, operates, acquires and owns a diverse portfolio of primarily Class A office space. The Company's portfolio totals 51.2 million square feet and 196 properties, including six properties under construction/redevelopment.
NYSE ended the session with Boston Properties sliding 0.63% to $73.04 on Thursday while NYSE fell 0.54% to $15,934.72.
Earnings Per Share
As for profitability, Boston Properties has a trailing twelve months EPS of $2.93.
PE Ratio
Boston Properties has a trailing twelve months price to earnings ratio of 24.95. Meaning, the purchaser of the share is investing $24.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.23%.
More news about Boston Properties.
3. Genworth Financial (GNW) – Premarket: -0.53%
Genworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.
NYSE ended the session with Genworth Financial rising 3.58% to $5.64 on Thursday while NYSE dropped 0.54% to $15,934.72.
Earnings Per Share
As for profitability, Genworth Financial has a trailing twelve months EPS of $0.84.
PE Ratio
Genworth Financial has a trailing twelve months price to earnings ratio of 6.72. Meaning, the purchaser of the share is investing $6.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.49%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Genworth Financial’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
Genworth Financial’s stock is valued at $5.64 at 07:34 EST, under its 52-week high of $5.82 and way above its 52-week low of $3.43.
More news about Genworth Financial.
4. Sun Communities (SUI) – Premarket: -0.12%
Sun Communities, Inc. is a REIT that, as of March 31, 2022, owned, operated, or had an interest in a portfolio of 603 developed MH, RV and marina properties comprising nearly 159,300 developed sites and over 45,700 wet slips and dry storage spaces in 39 states, Canada, Puerto Rico and the UK.
NYSE ended the session with Sun Communities falling 0.37% to $160.00 on Thursday while NYSE dropped 0.54% to $15,934.72.
Earnings Per Share
As for profitability, Sun Communities has a trailing twelve months EPS of $1.69.
PE Ratio
Sun Communities has a trailing twelve months price to earnings ratio of 94.79. Meaning, the purchaser of the share is investing $94.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.73%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 28, 2022, the estimated forward annual dividend rate is 3.52 and the estimated forward annual dividend yield is 2.66%.
More news about Sun Communities.
5. Koninklijke Philips (PHG) – Premarket: -0.06%
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
NYSE ended the session with Koninklijke Philips sliding 1.05% to $17.38 on Thursday while NYSE slid 0.54% to $15,934.72.
Earnings Per Share
As for profitability, Koninklijke Philips has a trailing twelve months EPS of $1.56.
PE Ratio
Koninklijke Philips has a trailing twelve months price to earnings ratio of 11.12. Meaning, the purchaser of the share is investing $11.12 for every dollar of annual earnings.
More news about Koninklijke Philips.
6. Vanguard Short-Term (VTIP) – Premarket: 0%
NASDAQ ended the session with Vanguard Short-Term rising 0.23% to $47.08 on Thursday while NASDAQ slid 1.68% to $11,910.52.
Earnings Per Share
As for profitability, Vanguard Short-Term has a trailing twelve months EPS of $6.24.
More news about Vanguard Short-Term.
7. Paychex (PAYX) – Premarket: 0.01%
Paychex, Inc. provides integrated human capital management solutions for human resources (HR), payroll, benefits, and insurance services for small to medium-sized businesses in the United States, Europe, and India. It offers payroll processing services; payroll tax administration services; employee payment services; and regulatory compliance services, such as new-hire reporting and garnishment processing. The company also provides HR solutions, including payroll, employer compliance, HR and employee benefits administration, risk management outsourcing, and the on-site availability of a professionally trained HR representative; and retirement services administration, including plan implementation, ongoing compliance with government regulations, employee and employer reporting, participant and employer online access, electronic funds transfer, and other administrative services. In addition, it offers cloud-based HR administration software products for employee benefits management and administration, time and attendance, digital communication solutions, recruiting, and onboarding solutions; plan administration outsourcing and state unemployment insurance services; various business services to small to medium-sized businesses comprising payroll funding and outsourcing services, which include payroll processing, invoicing, and tax preparation; and payment processing services, financial fitness programs, and a small-business loan resource center. Further, the company provides insurance services for property and casualty coverage, such as workers' compensation, business-owner policies, cyber security protection, and commercial auto, as well as health and benefits coverage, including health, dental, vision, and life. It markets and sells its services primarily through its direct sales force. The company was founded in 1971 and is headquartered in Rochester, New York.
NASDAQ ended the session with Paychex sliding 1.84% to $114.93 on Thursday while NASDAQ slid 1.68% to $11,910.52.
Earnings Per Share
As for profitability, Paychex has a trailing twelve months EPS of $2.92.
PE Ratio
Paychex has a trailing twelve months price to earnings ratio of 39.36. Meaning, the purchaser of the share is investing $39.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.54%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Paychex’s stock is considered to be overbought (>=80).
Moving Average
Paychex’s worth is under its 50-day moving average of $118.48 and under its 200-day moving average of $120.65.
Volume
Today’s last reported volume for Paychex is 1533190 which is 7.1% below its average volume of 1650510.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 7.8% and 21%, respectively.
More news about Paychex.
8. Garmin (GRMN) – Premarket: 0.02%
Garmin Ltd. designs, develops, manufactures, markets, and distributes a range of wireless devices in the Americas, the Asia Pacific, Australian Continent, Europe, the Middle East, and Africa. Its Fitness segment offers running and multi-sport watches; cycling products; activity tracking and smartwatch devices; and fitness and cycling accessories. This segment also provides Garmin Connect and Garmin Connect Mobile, which are web and mobile platforms; and Connect IQ, an application development platform. The company's Outdoor segment offers adventure watches, outdoor handhelds, golf devices and mobile apps, and dog tracking and training devices. Its Aviation segment designs, manufactures, and markets various aircraft avionics solutions comprising integrated flight decks, electronic flight displays and instrumentation, navigation and communication products, automatic flight control systems and safety-enhancing technologies, audio control systems, engine indication systems, traffic awareness and avoidance solutions, ADS-B and transponder solutions, weather information and avoidance solutions, datalink and connectivity solutions, portable GPS navigators and wearables, and various services products. The company's Marine segment provides chartplotters and multi-function displays, cartography products, fish finders, sonar products, autopilot systems, radars, compliant instrument displays and sensors, VHF communication radios, handhelds and wearable devices, sailing products, entertainment, digital switching products, and trolling motors. Its Auto segment offers embedded computing models and infotainment systems; personal navigation devices; and cameras. The company sells its products through independent retailers, online retailers, dealers, distributors, installation and repair shops, and original equipment manufacturers, as well as an online webshop, garmin.com. Garmin Ltd. was founded in 1989 and is based in Schaffhausen, Switzerland.
NASDAQ ended the session with Garmin dropping 1.78% to $96.99 on Thursday, following the last session’s downward trend. NASDAQ dropped 1.68% to $11,910.52, following the last session’s downward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Garmin has a trailing twelve months EPS of $5.47.
PE Ratio
Garmin has a trailing twelve months price to earnings ratio of 17.74. Meaning, the purchaser of the share is investing $17.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.47%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Garmin’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
Garmin’s stock is valued at $96.99 at 07:34 EST, way below its 52-week high of $129.07 and way higher than its 52-week low of $76.37.
More news about Garmin.
9. Cenovus Energy (CVE) – Premarket: 0.05%
Cenovus Energy Inc., together with its subsidiaries, develops, produces, and markets crude oil, natural gas liquids, and natural gas in Canada, the United States, and the Asia Pacific region. The company operates through Oil Sands, Conventional, Offshore, Canadian Manufacturing, U.S. Manufacturing, and Retail segments. The Oil Sands segment develops and produces bitumen and heavy oil in northern Alberta and Saskatchewan. This segments Foster Creek, Christina Lake, Sunrise, and Tucker oil sands projects, as well as Lloydminster thermal and conventional heavy oil assets The Conventional segment holds assets primarily located in Elmworth-Wapiti, Kaybob-Edson, Clearwater, and Rainbow Lake operating in Alberta and British Columbia, as well as interests in various natural gas processing facilities. The offshore segment engages in the exploration and development activities. The Canadian Manufacturing segment includes the owned and operated Lloydminster upgrading and asphalt refining complex, which upgrades heavy oil and bitumen into synthetic crude oil, diesel fuel, asphalt, and other ancillary products, as well as owns and operates the Bruderheim crude-by-rail terminal and two ethanol plants. The U.S. Manufacturing segment comprises the refining of crude oil to produce diesel, gasoline, jet fuel, asphalt, and other products. The Retail segment consists of marketing of its own and third-party refined petroleum products through retail, commercial, and bulk petroleum outlets, as well as wholesale channels. Cenovus Energy Inc. was founded in 2009 and is headquartered in Calgary, Canada.
NYSE ended the session with Cenovus Energy rising 0.23% to $19.50 on Thursday, after two consecutive sessions in a row of gains. NYSE fell 0.54% to $15,934.72, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Cenovus Energy has a trailing twelve months EPS of $-1.58.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.83%.
Sales Growth
Cenovus Energy’s sales growth is 14.3% for the ongoing quarter and 6.8% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 242.9% and 517.6%, respectively.
More news about Cenovus Energy.
10. Altria Group (MO) – Premarket: 0.19%
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
NYSE ended the session with Altria Group dropping 0.13% to $46.50 on Thursday while NYSE dropped 0.54% to $15,934.72.
Earnings Per Share
As for profitability, Altria Group has a trailing twelve months EPS of $2.33.
PE Ratio
Altria Group has a trailing twelve months price to earnings ratio of 19.95. Meaning, the purchaser of the share is investing $19.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 391.08%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 13, 2022, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 8.22%.
More news about Altria Group.
Stay up to date with our premarket winners and losers daily report
